Investment House LLC Amgen Inc Transaction History

Investment House LLC

  • $1.83 Billion
  • Q3 2024

A detailed history of Investment House LLC transactions in Amgen Inc stock. As of the latest transaction made, Investment House LLC holds 34,581 shares of AMGN stock, worth $8.97 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
34,581
Previous 33,171 4.25%
Holding current value
$8.97 Million
Previous $10.4 Million 7.51%
% of portfolio
0.61%
Previous 0.59%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$309.38 - $337.38 $436,225 - $475,705
1,410 Added 4.25%
34,581 $11.1 Million
Q2 2024

Jul 22, 2024
BUY
$262.75 - $319.31 $45,981 - $55,879
175 Added 0.53%
33,171 $10.4 Million
Q1 2024

May 02, 2024
BUY
$268.87 - $324.56 $1.23 Million - $1.49 Million
4,591 Added 16.16%
32,996 $9.38 Million
Q4 2023

Feb 05, 2024
BUY
$255.7 - $288.46 $37,076 - $41,826
145 Added 0.51%
28,405 $8.18 Million
Q3 2023

Nov 09, 2023
SELL
$218.65 - $271.46 $444,078 - $551,335
-2,031 Reduced 6.7%
28,260 $7.6 Million
Q2 2023

Aug 08, 2023
SELL
$214.27 - $253.37 $2.49 Million - $2.94 Million
-11,606 Reduced 27.7%
30,291 $6.73 Million
Q1 2023

May 09, 2023
SELL
$225.79 - $275.2 $378,649 - $461,510
-1,677 Reduced 3.85%
41,897 $10.1 Million
Q4 2022

Feb 07, 2023
SELL
$229.03 - $291.01 $109,934 - $139,684
-480 Reduced 1.09%
43,574 $11.4 Million
Q3 2022

Oct 31, 2022
BUY
$224.46 - $253.15 $332,649 - $375,168
1,482 Added 3.48%
44,054 $9.93 Million
Q2 2022

Aug 09, 2022
BUY
$230.71 - $256.74 $1.23 Million - $1.37 Million
5,340 Added 14.34%
42,572 $10.4 Million
Q1 2022

Apr 14, 2022
SELL
$219.27 - $242.57 $81,349 - $89,993
-371 Reduced 0.99%
37,232 $9 Million
Q4 2021

Feb 09, 2022
SELL
$198.88 - $227.6 $642,382 - $735,148
-3,230 Reduced 7.91%
37,603 $8.46 Million
Q3 2021

Nov 12, 2021
SELL
$212.27 - $248.7 $1.29 Million - $1.51 Million
-6,060 Reduced 12.92%
40,833 $8.68 Million
Q2 2021

Jul 20, 2021
BUY
$233.58 - $259.14 $198,543 - $220,269
850 Added 1.85%
46,893 $11.4 Million
Q1 2021

May 06, 2021
SELL
$221.91 - $258.6 $672,165 - $783,299
-3,029 Reduced 6.17%
46,043 $11.5 Million
Q4 2020

Jan 13, 2021
BUY
$216.38 - $257.67 $104,944 - $124,969
485 Added 1.0%
49,072 $11.3 Million
Q3 2020

Nov 06, 2020
BUY
$234.65 - $260.95 $3,050 - $3,392
13 Added 0.03%
48,587 $12.3 Million
Q2 2020

Jul 13, 2020
SELL
$197.81 - $242.74 $498,679 - $611,947
-2,521 Reduced 4.93%
48,574 $11.5 Million
Q1 2020

Apr 08, 2020
BUY
$182.24 - $241.7 $580,798 - $770,297
3,187 Added 6.65%
51,095 $10.4 Million
Q4 2019

Feb 05, 2020
SELL
$189.21 - $243.2 $259,596 - $333,670
-1,372 Reduced 2.78%
47,908 $11.5 Million
Q3 2019

Nov 12, 2019
BUY
$174.11 - $208.62 $82,528 - $98,885
474 Added 0.97%
49,280 $9.54 Million
Q2 2019

Aug 05, 2019
BUY
$166.7 - $195.41 $690,804 - $809,779
4,144 Added 9.28%
48,806 $8.99 Million
Q1 2019

May 03, 2019
SELL
$180.87 - $203.88 $9,043 - $10,194
-50 Reduced 0.11%
44,662 $8.49 Million
Q4 2018

Feb 06, 2019
BUY
$178.4 - $208.25 $107,932 - $125,991
605 Added 1.37%
44,712 $8.7 Million
Q3 2018

Oct 09, 2018
SELL
$185.29 - $208.89 $1.01 Million - $1.14 Million
-5,463 Reduced 11.02%
44,107 $9.14 Million
Q2 2018

Jul 10, 2018
BUY
$166.05 - $186.51 $5,645 - $6,341
34 Added 0.07%
49,570 $9.15 Million
Q1 2018

May 08, 2018
SELL
$169.43 - $198.0 $43,543 - $50,886
-257 Reduced 0.52%
49,536 $8.45 Million
Q4 2017

Jan 31, 2018
SELL
$168.79 - $188.59 $25,318 - $28,288
-150 Reduced 0.3%
49,793 $8.66 Million
Q3 2017

Oct 30, 2017
BUY
$167.29 - $191.0 $8.35 Million - $9.54 Million
49,943
49,943 $9.31 Million

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $139B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Investment House LLC Portfolio

Follow Investment House LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment House LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment House LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email